Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You were already enrolled in a study called JOY-ALZ before your doctor decided to prescribe a medication called LEQEMBI
- Your doctor has already decided that you should be treated with LEQEMBI
- You are willing to sign a written consent form allowing your medical information to be shared with a company called Eisai Korea Inc.
Who may not be able to join:
- You are currently taking part in another clinical trial that involves a treatment or intervention
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-2-3451-5533
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Adverse Events of Special Interest (AESIs); Exposure-adjusted Incidence Rate of AESIs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.